Avid Bioservices Inc (CDMO)

[biopharm]

Saiid ties to Ambit and Intrexon (Peregrine direct ties shown below)

You may be correct and you may be wrong but do you not wonder about Peregrine collaborations they "CLAIMED" they had ..dozens ?

One I am curious about is Ambit Biosciences after it was posted an employee Sklenar was working with Peregrine and Ambit...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114368100

CS1FR Ambit program ( PS Targeting ?? )
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=103209171

....one must slowly read above and now ask yourself why was


June 17, 2010
Mr. Zarrabian currently serves on the board of biopharmaceutical company Ambit Biosciences, and chemistry eCommerce portal, eMolecules.
http://www.businesswire.com/news/home/20100617005261/en/Cyntellect-Appoints-Saiid-Zarrabian-CEO

Deals Involving Said Zarrabian:

Deals involving Saiid Zarrabian
$200,000,000 raised with Intrexon Corp on August, 2015
$150,000,000 raised with Intrexon Corp on May, 2013
$25,000,002 raised with Intrexon Corp on November, 2012
$75,000,006 raised with Intrexon Corp on April, 2012
$1,092,344 raised with Intrexon Corp on November, 2011
$17,000,004 raised with Intrexon Corp on September, 2011
$91,825,055 raised with Intrexon Corp on June, 2011
$550,001 raised with Intrexon Corp on May, 2011
$1,013,625 raised with Intrexon Corp on February, 2011
$17,403,901 raised with Intrexon Corp on March, 2010
$25,000,000 raised with Intrexon Corp on January, 2010
$9,999,999 raised with Intrexon Corp on June, 2009

$65,000,000 raised with Ambit Biosciences Corp on May, 2013
$25,000,000 raised with Ambit Biosciences Corp on November, 2012
$7,066,803 raised with Ambit Biosciences Corp on May, 2012
$22,000,006 raised with Ambit Biosciences Corp on June, 2011
$14,999,327 raised with Ambit Biosciences Corp on October, 2010
$12,000,000 raised with Ambit Biosciences Corp on April, 2010
Undisclosed raised with Ambit Biosciences Corp on July, 2009
$6,428,542 raised with Ambit Biosciences Corp on June, 2009

http://www.whogotfunded.com/people/98975-saiid-zarrabian

-------------

Now pay attention and look how we crossover to Peregrine ties with
Sunil Chada (March 2014 patent) works at Intrexon where Saiid was pulling in money for and on BOD so Saiid knows well it seems, Peregrine!!

....on patent in March 2014 with Peregrine KOLs Dmitry G. Scott A. And Peregrine Head of Medical Oncology Kerstin Menander and employed Intrexon (also special advisor to CSO Moonshots program MD Anderson
...
...
UT MD Anderson Cancer Center - Cancer Prevention Research Training Program
2013 – 2014 (1 year)Houston, TX
Intrexon Corporation

Senior Vice President, Translational Medicine
Intrexon Corporation
2008 – 2011 (3 years)Blacksburg, VA
...
...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112091582

-------

As stated before, we all need to start vetting Ronin Capital Management and when you CLEARLY see MANY of the puzzle pieces from past like above and we have Saiid being one of the three BOD that Ronin has somehow chosen and downplays PS Targeting ....

What did Ronin reps question Saiid about re Intrexon and Ambit ??? ...and are there ANY conflicts of interest??

I could go on and on....and already showed links to CSM in Fargo ... so all should start taking notes because this is just the tip of iceberg as I would like a full and complete disclosure from Ronin on any ANY conflicts of interest moving forward or I certainly am not about to hand over a vote when the PS Targeting IP is downplayed as is evident from Ronin letter to shareholders